Founded in 1982, this nationally recognized behavioral health platform owns one of the most established intellectual-property portfolios in addiction treatment and relapse prevention. Revenue is generated across four complementary streams: live training and consulting, published books and workbooks, professional certification, and online courses.
What the buyer acquires:
• A proprietary, trademark-protected clinical methodology — a relapse-prevention and behavior-change framework widely recognized and cited across the addiction-treatment field.
• 79 copyrighted titles — clinical guides, workbooks, and assessments, now fulfilled through print-on-demand (no inventory or warehousing).
• Registered trademarks plus six premium domains, including two category-defining URLs in the recovery space.
• A certification database of ~2,000 endorsed clinicians, supporting recurring annual recertification fees ($50/yr) plus new standard ($95) and advanced ($150) certifications.
• Approved continuing-education (CE) provider status with major accrediting bodies — credentials that take years for a new entrant to earn.
• 15–20 drafted but unpublished manuscripts — a built-in product pipeline requiring only modest editorial work.
• Dormant international translation rights across five languages.
Institutional validation: The curriculum is embedded within a state correctional system's counselor-certification program on a sole-source basis (no authorized substitute). This relationship has generated $209,000+ since 2023 and is a template for expansion into additional systems.
Financial profile: Revenue grew from ~$137K (2023) to ~$229K (2025), roughly 29% CAGR. Three-year average seller's discretionary earnings (SDE) of ~$89K. No debt, no litigation, no options or affiliated entities. Single S-corporation, clean cap table, three equal owners.
The opportunity: The business is run by three owner-partners on a lean cost base and has never had a dedicated sales, marketing, or licensing function — nearly every growth lever is untouched. An independent 2025 valuation identified meaningful annual IP licensing and enforcement potential that remains uncommercialized. Natural acquirers include treatment-center operators (deploy the curriculum across facilities and certify staff), behavioral-health publishers (refresh and reissue the catalog), and CEU/training platforms (convert content into on-demand courses and subscriptions).
Owners will support a transition and are open to a structure that shares future licensing upside via an earnout. A full Confidential Information Memorandum is available to qualified buyers under NDA.